A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127), which fundamentally misconstrues the role of pharmacy benefit companies, unfairly proposes to take away employers’
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on S. 1388, the “Prescription Drug Pricing for the People Act.” PCMA, the trade association for America’s pharmacy benefit managers (PBMs), today endorsed S. 1388, the “Prescription
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
Patient Care Pharmacy benefit companies work to lower prescription drug costs, improve patient access to prescription drugs, and offer benefits that protect a patient’s overall health. Health care plans hire pharmacy benefit companies, PBMs, to secure lower costs for prescription
Paying pharmacies more for dispensing medications will raise prescription drug costs without improving value.
PBMs are committed to helping the patients we serve stay at home safely with reliable, convenient access to their needed prescription drugs. PBMs recognize that home delivery can provide an alternative way of safely accessing needed maintenance medications and
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today released the following statement on the Senate Finance Committee hearing, “Drug Pricing in America: A Prescription for Change, Part III:” “We applaud the Senate Finance Committee
©2024 PCMA. All Rights Reserved.
